Simplex Trading
SVA

Simplex Trading’s Sinovac Biotech, Ltd SVA Stock Holding History

Simplex Trading’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16
Closed -$11K – 8463
2018
Q4 		$11K Sell
16
-10
-38% -$73 ﹤0.01% 5823
2018
Q3 		$19K Buy
26
+16
+160% +$115 ﹤0.01% 6020
2018
Q2 		$7K Buy
+10
New +$79 ﹤0.01% 6587
2017
Q1 		– Sell
-40
Closed -$9K – 7466
2016
Q4 		$9K Buy
+40
New +$241 ﹤0.01% 3901

Other funds holding SVA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RQS
Ramsey Quantitative Systems Louisville, Kentucky $112M AUM 16.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's SVA Position: Q1 2018 in Review

Simplex Trading sold out of Sinovac Biotech, Ltd (SVA) in Q1 2018, closing a stake of 274 shares — an estimated $2.26K sold.

Simplex Trading first reported a position in SVA in Q2 2016 and held it in 6 quarters. The position peaked at $48K in Q3 2016. 29 funds tracked by Wall St. Rank hold SVA as of Q1 2018.

  • Simplex Trading reported no remaining Sinovac Biotech, Ltd position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 274 Sinovac Biotech, Ltd shares in Q1 2018, an estimated $2.26K.
  • Simplex Trading first reported a position in Sinovac Biotech, Ltd in Q2 2016 and held it in 6 quarters.
  • Simplex Trading's Sinovac Biotech, Ltd position peaked at $48K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.